BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19637961)

  • 1. Closed-hub systems with protected connections and the reduction of risk of catheter-related bloodstream infection in pediatric patients receiving intravenous prostanoid therapy for pulmonary hypertension.
    Ivy DD; Calderbank M; Wagner BD; Dolan S; Nyquist AC; Wade M; Nickels WM; Doran AK
    Infect Control Hosp Epidemiol; 2009 Sep; 30(9):823-9. PubMed ID: 19637961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bloodstream infections in patients given treatment with intravenous prostanoids.
    Kallen AJ; Lederman E; Balaji A; Trevino I; Petersen EE; Shoulson R; Saiman L; Horn EM; Gomberg-Maitland M; Barst RJ; Srinivasan A
    Infect Control Hosp Epidemiol; 2008 Apr; 29(4):342-9. PubMed ID: 18462147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bloodstream infections in patients with pulmonary arterial hypertension treated with intravenous prostanoids: insights from the REVEAL REGISTRY®.
    Kitterman N; Poms A; Miller DP; Lombardi S; Farber HW; Barst RJ
    Mayo Clin Proc; 2012 Sep; 87(9):825-34. PubMed ID: 22883740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of diluent pH on bloodstream infection rates in patients receiving IV treprostinil for pulmonary arterial hypertension.
    Rich JD; Glassner C; Wade M; Coslet S; Arneson C; Doran A; Gomberg-Maitland M
    Chest; 2012 Jan; 141(1):36-42. PubMed ID: 21659437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of catheter-related infections using a closed hub system in patients with pulmonary arterial hypertension.
    Akagi S; Matsubara H; Ogawa A; Kawai Y; Hisamatsu K; Miyaji K; Munemasa M; Fujimoto Y; Kusano KF; Ohe T
    Circ J; 2007 Apr; 71(4):559-64. PubMed ID: 17384460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central venous catheter-related blood stream infections in patients receiving intravenous iloprost for pulmonary hypertension.
    Sammut D; Elliot CA; Kiely DG; Armstrong IJ; Martin L; Wilkinson J; Sephton P; Jones J; Hamilton N; Hurdman J; McLellan E; Sabroe I; Condliffe R
    Eur J Clin Microbiol Infect Dis; 2013 Jul; 32(7):883-9. PubMed ID: 23388830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bloodstream infections among patients treated with intravenous epoprostenol or intravenous treprostinil for pulmonary arterial hypertension--seven sites, United States, 2003-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(8):170-2. PubMed ID: 17332729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High incidence of bloodstream infection due to gram-negative bacilli in patients with pulmonary hypertension receiving intravenous treprostinil.
    López-Medrano F; Fernández-Ruiz M; Ruiz-Cano MJ; Barrios E; Vicente-Hernández M; Aguado JM; Escribano P
    Arch Bronconeumol; 2012 Dec; 48(12):443-7. PubMed ID: 22858303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased rate of catheter-related bloodstream infection associated with use of a needleless mechanical valve device at a long-term acute care hospital.
    Salgado CD; Chinnes L; Paczesny TH; Cantey JR
    Infect Control Hosp Epidemiol; 2007 Jun; 28(6):684-8. PubMed ID: 17520541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension.
    Doran AK; Ivy DD; Barst RJ; Hill N; Murali S; Benza RL;
    Int J Clin Pract Suppl; 2008 Jul; (160):5-9. PubMed ID: 18638170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cohort study of the pathogenesis and molecular epidemiology of catheter-related bloodstream infection in neonates with peripherally inserted central venous catheters.
    Garland JS; Alex CP; Sevallius JM; Murphy DM; Good MJ; Volberding AM; Hofer LL; Gordon BJ; Maki DG
    Infect Control Hosp Epidemiol; 2008 Mar; 29(3):243-9. PubMed ID: 18220483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors for the development of central line-associated bloodstream infection due to gram-negative bacteria in intensive care unit patients after surgery.
    Sreeramoju PV; Tolentino J; Garcia-Houchins S; Weber SG
    Infect Control Hosp Epidemiol; 2008 Jan; 29(1):51-6. PubMed ID: 18171187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous catheter infections in pulmonary arterial hypertension.
    Gaine S; Gomberg-Maitland M
    Int J Clin Pract Suppl; 2008 Jul; (160):3-4. PubMed ID: 18638169
    [No Abstract]   [Full Text] [Related]  

  • 14. [Transition from intravenous to subcutaneous prostacyclin in pulmonary hypertension].
    Escribano Subías P; Cea-Calvo L; Tello de Menesses R; Gómez Sánchez MA; Delgado Jiménez JF; Sáenz de la Calzada C
    Rev Esp Cardiol; 2003 Aug; 56(8):818-21. PubMed ID: 12892628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gram-negative bloodstream infections in hematopoietic stem cell transplant patients: the roles of needleless device use, bathing practices, and catheter care.
    Toscano CM; Bell M; Zukerman C; Shelton W; Novicki TJ; Nichols WG; Corey L; Jarvis WR
    Am J Infect Control; 2009 May; 37(4):327-34. PubMed ID: 19406332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chryseomonas luteola bloodstream infection in a pediatric patient with pulmonary arterial hypertension receiving intravenous treprostinil therapy.
    Wen AY; Weiss IK; Kelly RB
    Infection; 2013 Jun; 41(3):719-22. PubMed ID: 23329255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability and antimicrobial effectiveness of treprostinil sodium in Sterile Diluent for Flolan.
    Zaccardelli D; Phares K; Jeffs R; Doran A; Wade M
    Int J Clin Pract; 2010 Jun; 64(7):885-91. PubMed ID: 20584221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System: Results of the DelIVery for PAH Trial.
    Bourge RC; Waxman AB; Gomberg-Maitland M; Shapiro SM; Tarver JH; Zwicke DL; Feldman JP; Chakinala MM; Frantz RP; Torres F; Cerkvenik J; Morris M; Thalin M; Peterson L; Rubin LJ
    Chest; 2016 Jul; 150(1):27-34. PubMed ID: 27396777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution and aetiological shift of catheter-related bloodstream infection in a whole institution: the microbiology department may act as a watchtower.
    Rodríguez-Créixems M; Muñoz P; Martín-Rabadán P; Cercenado E; Guembe M; Bouza E
    Clin Microbiol Infect; 2013 Sep; 19(9):845-51. PubMed ID: 23565810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micrococcus-associated central venous catheter infection in patients with pulmonary arterial hypertension.
    Oudiz RJ; Widlitz A; Beckmann XJ; Camanga D; Alfie J; Brundage BH; Barst RJ
    Chest; 2004 Jul; 126(1):90-4. PubMed ID: 15249447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.